SR 141716A

• Supplier: R&D Systems
• Catalog: 0923
• Prices: $99.00, $419.00
• Sizes: 10 mg, 50 mg
• Cas Number: 158681-13-1
• Chemical Name: N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamidehydrochloride
• Formula: C22H21Cl3N4O.HCl
• Molecular Weight: 500.25
• Purity: >99%

Product References

Acute Metabolic Effects of Olanzapine Depend on Dose and Injection Site. - Acute Metabolic Effects of Olanzapine Depend on Dose and Injection Site.

Klingerman CM, Stipanovic ME, Hajnal A, Lynch CJ. Dose Response. 2015 Nov 26;13(4):1559325815618915.

(4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride - (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride

Mahmoud MM, Olszewska T, Liu H, Shore DM, Hurst DP, Reggio PH, Lu D, Kendall DA. Mol Pharmacol. 2015 Feb;87(2):197-206.

Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid - Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid

Tang AH, Alger BE. J Neurosci. 2015 Mar 4;35(9):3938-45.

Novel insights into CB1 cannabinoid receptor signaling: a key interaction - Novel insights into CB1 cannabinoid receptor signaling: a key interaction

Marcu J, Shore DM, Kapur A, Trznadel M, Makriyannis A, Reggio PH, Abood ME. J Pharmacol Exp Ther. 2013 May;345(2):189-97.

Reversible gating of endocannabinoid plasticity in the amygdala by chronic - Reversible gating of endocannabinoid plasticity in the amygdala by chronic

Sumislawski JJ, Ramikie TS, Patel S. Neuropsychopharmacology. 2011 Dec;36(13):2750-61.

Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane - Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane

Kapur A, Samaniego P, Thakur GA, Makriyannis A, Abood ME. J Pharmacol Exp Ther. 2008 Apr;325(1):341-8.

Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells - Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells

Graham ES, Ball N, Scotter EL, Narayan P, Dragunow M, Glass M. J Biol Chem. 2006 Sep 29;281(39):29085-95. Epub 2006 Jul 24.

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of - Effects of cannabinoid receptor agonists on neuronally-evoked contractions of

Martin RS, Luong LA, Welsh NJ, Eglen RM, Martin GR, MacLennan SJ. Br J Pharmacol. 2000 Apr;129(8):1707-15.

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 - Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1

MacLennan SJ, Reynen PH, Kwan J, Bonhaus DW. Br J Pharmacol. 1998 Jun;124(4):619-22.